Physician profile
Corinne Rebecca Young
NPI 1578581021
$272,065.00
in general payments reported to CMS, 2019-2025
54 companies · $170K in 2025
The $170K reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $9,489 · 2022: $11K · 2023: $9,942 · 2024: $71K · 2025: $170K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $131K · Consulting Fee: $57K · Travel and Lodging: $45K · Food and Beverage: $15K · Honoraria: $2,000 · Education: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $131,384.13 |
| Consulting Fee | $57,319.25 |
| Travel and Lodging | $45,473.63 |
| Food and Beverage | $15,298.96 |
| Honoraria | $2,000.00 |
| Education | $168.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $111,039.32 | 2021-2025 | Dupixent |
| Genzyme Corporation | $79,846.38 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $20,190.01 | 2021-2025 | Breztri, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $19,759.65 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Grifols USA, LLC | $10,809.13 | 2021-2025 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $7,483.94 | 2021-2025 | Ofev, Spiriva, Jascayd |
| Inspire Medical Systems, INC. | $5,770.11 | 2021-2025 | Inspire |
| Regeneron Pharmaceuticals, INC. | $3,632.00 | 2024-2025 | Dupixent |
| Merck Sharp & Dohme LLC | $3,418.87 | 2023-2025 | Winrevair, Zerbaxa, Recarbrio |
| Pulmonx Corporation | $2,192.05 | 2025 | Zephyr Endobronchial Valve |
| Takeda Pharmaceuticals U.S.A., INC. | $1,977.51 | 2021-2025 | Glassia, Hyqvia |
| United Therapeutics Corporation | $1,368.39 | 2021-2025 | Tyvaso, Orenitram, Remodulin |
| Actelion Pharmaceuticals US, INC. | $560.87 | 2021-2025 | Opsumit, Uptravi, Opsynvi |
| Insmed, INC. | $414.45 | 2021-2025 | Arikayce, Brinsupri |
| Bayer Healthcare Pharmaceuticals INC. | $397.72 | 2021-2025 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $284.29 | 2023-2024 | Yupelri |
| Amgen INC. | $267.31 | 2021-2025 | Tezspire, Tavneos |
| Electromed, INC. | $231.99 | 2023-2025 | Smartvest |
| Novartis Pharmaceuticals Corporation | $217.90 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $215.42 | 2022-2024 | |
| Baxter Healthcare | $169.84 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Abbvie INC. | $169.62 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $163.10 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $137.32 | 2021-2025 | Acthar |
| Harmony Biosciences LLC | $125.00 | 2022-2025 | Wakix |
| Verona Pharma, INC. | $83.50 | 2025 | Ohtuvayre |
| Astellas Pharma US INC | $82.07 | 2022-2024 | Cresemba |
| Viatris Specialty LLC | $76.24 | 2025 | Yupelri |
| Axsome Therapeutics, INC. | $69.43 | 2023-2025 | Sunosi |
| Alexion Pharmaceuticals, INC. | $66.93 | 2021-2024 | Ultomiris |
| Grifols Shared Services North America, INC. | $64.01 | 2024-2025 | Prolastin-C Liquid |
| Jazz Pharmaceuticals INC. | $63.05 | 2022-2023 | |
| Philips North America LLC | $60.63 | 2023-2025 | Vest Therapy Und |
| Avadel Cns Pharmaceuticals, LLC | $56.34 | 2025 | Lumryz |
| Lilly USA, LLC | $54.23 | 2025 | Zepbound |
| Teva Pharmaceuticals USA, INC. | $53.27 | 2022 | |
| Pfizer INC. | $52.82 | 2021-2023 | |
| Vifor Pharma, INC. | $50.63 | 2024 | Veltassa |
| Inogen, INC. | $42.79 | 2022-2025 | |
| Genentech USA, INC. | $38.46 | 2021-2025 | Tecentriq |
| Gilead Sciences, INC. | $37.12 | 2022-2023 | |
| Liquidia Technologies, INC. | $34.18 | 2025 | Yutrepia |
| Genentech, INC. | $28.10 | 2022 | |
| Pharming Healthcare, INC. | $27.23 | 2023 | Ruconest |
| Aerin Medical INC. | $25.78 | 2024 | |
| Resmed Corp | $21.91 | 2021 | |
| Bard Peripheral Vascular, INC. | $20.06 | 2025 | Pleurx |
| Ani Pharmaceuticals, INC. | $19.15 | 2023 | Purified Cortrophin Gel |
| Scpharmaceuticals INC. | $17.34 | 2025 | |
| La Jolla Pharmaceutical Company | $17.22 | 2024 | Giapreza |
| Adma Biomanufacturing LLC | $17.14 | 2021 | |
| Movair INC | $15.55 | 2025 | Luisa |
| Mirati Therapeutics, INC. | $14.89 | 2023 | Krazati |
| Olympus America INC. | $12.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corinne Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.